Italy· 045253010
VEMLIDY*30 cpr rivestite 25 mg flacone
A tenofovir alafenamide product containing tenofovir alafenamide, registered in Italy by GILEAD SCIENCES IRELAND UC, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Tenofovir alafenamide is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AF13 (tenofovir alafenamide), each read from that country’s own register.
- This record: Italy
- 8 of them publish a price we can compare per daily dose
Tenofovir alafenamide · ATC J05AF13
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tenofovir alafenamide costs, country by country.
Normalised to the WHO defined daily dose (25 mg), so markets compare like for like.
- Italy: $18.37 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tenofovir alafenamide · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$20.29
- IT Italy$18.37
The record
At a glance
- Active substance
- Tenofovir alafenamide
- Manufacturer
- GILEAD SCIENCES IRELAND UC
- Country
- Italy (IT)
- ATC code
- J05AF13
- ATC class
- Tenofovir alafenamide
- Defined daily dose
- 25 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic045253010VEMLIDY*30 cpr rivestite 25 mg flaconeEUR 484.08
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tenofovir alafenamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVemlidyGilead Sciences Ireland UC
- NorwayVemlidyGilead Sciences Ireland UC
- CzechiaVEMLIDYGilead Sciences Ireland UC, Carrigtohill
- BelgiumGenvoya 90 mg - 90 mg - 120 mg - 6 mgGilead Sciences Ireland UC
- United KingdomVemlidy 25mg tabletsGilead Sciences Ltd
- IrelandVemlidy 25 mg film-coated tabletsGilead Sciences Ireland UC
- IcelandVemlidyGilead Sciences Ireland UC*
- Japanテノホビル アラフェナミドフマル酸塩ギリアド・サイエンシズ
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Tenofoviralafenamid Devatis
- Iceland · Vemlidy
- Liechtenstein · Vemlidy
- Netherlands · Tenofoviralafenamide Devatis
- Norway · Vemlidy
- Portugal · Tenofovir Alafenamida Humanis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff696fc6-9fff-43af-8b7e-a3b933f1c5cd GET /v1/drugs/ff696fc6-9fff-43af-8b7e-a3b933f1c5cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 484.08,
"source": "aifa",
"currency": "EUR",
"strength": "TENOFOVIR ALAFENAMIDE 25MG 30 UNITA' USO ORALE",
"substance": "Tenofovir alafenamide",
"equivalence_group": "JZY",
"transparency_flag": null
}See everything about tenofovir alafenamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.